Tag: Novartis vaccine business
CSL acquires Novartis flu division
CSL is set to become the second largest flu vaccine business in the world with the acquisition of a subsidiary of Swiss pharmaceutical multinational...
Featured Article
Good Design Australia opens entries for 2026 awards
For more than six decades, Good Design Australia has celebrated the power of design to shape innovation, industry, and everyday life. Its flagship program, the Australian Good Design Awards, recognises projects that show how thoughtful design can enhance products, services, systems, and communities.
